MEDIOS AG (ILM1.DE) Stock Fundamental Analysis
FRA:ILM1 - Deutsche Boerse Ag - DE000A1MMCC8 - Common Stock - Currency: EUR
Taking everything into account, ILM1 scores 4 out of 10 in our fundamental rating. ILM1 was compared to 24 industry peers in the Health Care Providers & Services industry. While ILM1 seems to be doing ok healthwise, there are quite some concerns on its profitability. ILM1 has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ILM1 had positive earnings in the past year.
In the past year ILM1 had a positive cash flow from operations.
ILM1 had positive earnings in each of the past 5 years.
ILM1 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ILM1 has a Return On Assets (1.34%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 2.46%, ILM1 is in line with its industry, outperforming 41.67% of the companies in the same industry.
ILM1 has a Return On Invested Capital of 2.52%. This is comparable to the rest of the industry: ILM1 outperforms 41.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ILM1 is below the industry average of 5.69%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.46% | ||
| ROIC | 2.52% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
1.3 Margins
ILM1's Profit Margin of 0.67% is on the low side compared to the rest of the industry. ILM1 is outperformed by 62.50% of its industry peers.
In the last couple of years the Profit Margin of ILM1 has declined.
With a Operating Margin value of 1.68%, ILM1 is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of ILM1 has declined.
ILM1 has a worse Gross Margin (8.04%) than 66.67% of its industry peers.
In the last couple of years the Gross Margin of ILM1 has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.68% | ||
| PM (TTM) | 0.67% | ||
| GM | 8.04% |
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ILM1 is destroying value.
ILM1 has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ILM1 has more shares outstanding
ILM1 has a worse debt/assets ratio than last year.
2.2 Solvency
ILM1 has an Altman-Z score of 2.89. This is not the best score and indicates that ILM1 is in the grey zone with still only limited risk for bankruptcy at the moment.
ILM1's Altman-Z score of 2.89 is amongst the best of the industry. ILM1 outperforms 87.50% of its industry peers.
The Debt to FCF ratio of ILM1 is 3.58, which is a good value as it means it would take ILM1, 3.58 years of fcf income to pay off all of its debts.
ILM1 has a Debt to FCF ratio of 3.58. This is in the better half of the industry: ILM1 outperforms 79.17% of its industry peers.
A Debt/Equity ratio of 0.41 indicates that ILM1 is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.41, ILM1 belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | 3.58 | ||
| Altman-Z | 2.89 |
ROIC/WACC0.38
WACC6.57%
2.3 Liquidity
ILM1 has a Current Ratio of 2.02. This indicates that ILM1 is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.02, ILM1 belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
A Quick Ratio of 1.48 indicates that ILM1 should not have too much problems paying its short term obligations.
ILM1 has a Quick ratio of 1.48. This is amongst the best in the industry. ILM1 outperforms 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.48 |
3. Growth
3.1 Past
ILM1 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.38%.
Measured over the past years, ILM1 shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.00% on average per year.
Looking at the last year, ILM1 shows a small growth in Revenue. The Revenue has grown by 5.51% in the last year.
Measured over the past years, ILM1 shows a very strong growth in Revenue. The Revenue has been growing by 29.51% on average per year.
EPS 1Y (TTM)-35.38%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%-20.79%
Revenue 1Y (TTM)5.51%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%9.36%
3.2 Future
ILM1 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.69% yearly.
Based on estimates for the next years, ILM1 will show a small growth in Revenue. The Revenue will grow by 4.11% on average per year.
EPS Next Y8.93%
EPS Next 2Y21.1%
EPS Next 3Y15.69%
EPS Next 5YN/A
Revenue Next Year7.6%
Revenue Next 2Y6.04%
Revenue Next 3Y4.17%
Revenue Next 5Y4.11%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 22.90, the valuation of ILM1 can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ILM1 is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 28.88. ILM1 is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 10.60, the valuation of ILM1 can be described as reasonable.
ILM1's Price/Forward Earnings ratio is rather cheap when compared to the industry. ILM1 is cheaper than 87.50% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.20, ILM1 is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.9 | ||
| Fwd PE | 10.6 |
4.2 Price Multiples
ILM1's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ILM1 is cheaper than 83.33% of the companies in the same industry.
79.17% of the companies in the same industry are more expensive than ILM1, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.42 | ||
| EV/EBITDA | 6.88 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ILM1 does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ILM1's earnings are expected to grow with 15.69% in the coming years.
PEG (NY)2.56
PEG (5Y)N/A
EPS Next 2Y21.1%
EPS Next 3Y15.69%
5. Dividend
5.1 Amount
ILM1 does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILM1 (4/30/2025, 7:00:00 PM)
11.68
+0.32 (+2.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners39.37%
Inst Owner ChangeN/A
Ins Owners19.96%
Ins Owner ChangeN/A
Market Cap297.96M
Analysts87.14
Price Target28.08 (140.41%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.7%
PT rev (3m)-3.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-17.03%
EPS NY rev (3m)-36.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.92%
Revenue NY rev (3m)-1.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.9 | ||
| Fwd PE | 10.6 | ||
| P/S | 0.16 | ||
| P/FCF | 4.42 | ||
| P/OCF | 4.04 | ||
| P/B | 0.58 | ||
| P/tB | 996.51 | ||
| EV/EBITDA | 6.88 |
EPS(TTM)0.51
EY4.37%
EPS(NY)1.1
Fwd EY9.43%
FCF(TTM)2.64
FCFY22.61%
OCF(TTM)2.89
OCFY24.72%
SpS73.82
BVpS20
TBVpS0.01
PEG (NY)2.56
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.46% | ||
| ROCE | 4.15% | ||
| ROIC | 2.52% | ||
| ROICexc | 2.93% | ||
| ROICexgc | 13.05% | ||
| OM | 1.68% | ||
| PM (TTM) | 0.67% | ||
| GM | 8.04% | ||
| FCFM | 3.58% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ROICexc(3y)3.82%
ROICexc(5y)3.8%
ROICexgc(3y)12.89%
ROICexgc(5y)11.48%
ROCE(3y)5.38%
ROCE(5y)5.1%
ROICexcg growth 3Y-0.85%
ROICexcg growth 5Y-8.22%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-23.77%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
F-Score5
Asset Turnover2.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | 3.58 | ||
| Debt/EBITDA | 3.31 | ||
| Cap/Depr | 20.16% | ||
| Cap/Sales | 0.33% | ||
| Interest Coverage | 3.16 | ||
| Cash Conversion | 117.01% | ||
| Profit Quality | 536.78% | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.48 | ||
| Altman-Z | 2.89 |
F-Score5
WACC6.57%
ROIC/WACC0.38
Cap/Depr(3y)16.31%
Cap/Depr(5y)50.4%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.49%
Profit Quality(3y)264.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.38%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%-20.79%
EPS Next Y8.93%
EPS Next 2Y21.1%
EPS Next 3Y15.69%
EPS Next 5YN/A
Revenue 1Y (TTM)5.51%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%9.36%
Revenue Next Year7.6%
Revenue Next 2Y6.04%
Revenue Next 3Y4.17%
Revenue Next 5Y4.11%
EBIT growth 1Y0.94%
EBIT growth 3Y27.64%
EBIT growth 5Y18.54%
EBIT Next Year108.61%
EBIT Next 3Y31.86%
EBIT Next 5Y29.46%
FCF growth 1Y344.76%
FCF growth 3Y11.42%
FCF growth 5YN/A
OCF growth 1Y349%
OCF growth 3Y6.19%
OCF growth 5YN/A